Registration - In-house Organization

BIOTECANADA / Wendy Zatylny, President & CEO

Registration Information

In-house Organization name: BIOTECANADA
Responsible Officer Name: Wendy Zatylny, President & CEO
Responsible Officer Change History
Initial registration start date: 2005-04-05
Registration status: Active
Registration Number: 843632-354

Associated Communications

Total Number of Communication Reports: 351

Monthly communication reports in the last 6 months: 3

Version 30 of 36 (2015-11-11 to 2016-05-13)

Registration versions:

Version 30 of 36 (2015-11-11 to 2016-05-13)

Lobbying Information

Subject Matters

Agriculture
Budget
Consumer Issues
Economic Development
Employment and Training
Energy
Environment
Fisheries
Forestry
Government Procurement
Health
Immigration
Industry
Intellectual Property
International Relations
International Trade
Research and Development
Science and Technology
Small Business
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution, Regulation

CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS in respect of modern, science-based regulations to reflect rapidly changing new technologies
FOOD AND DRUGS ACT AND REGULATIONS in respect of minimizing regulatory burden and ensuring appropriate climate for the introduction of new technologies

Policies or Program

ACCESS & BENEFIT SHARING: TRIPS AGREEMENT in respect of protecting intellectual property and preventing increased uncertainty
ADVENTITIOUS PRESCENCE POLICY in respect of new agricultural biotechnology products
BIOSAFETY PROTOCOL in respect of Canada's participation in global discussions to ensure an enabling environment for safe new technologies
Clarify the administration of SR&ED program to ensure clinical trials and international research conducted in Canada qualifies as eligible expenses
Creation of a modern policy environment that recognizes international standards and reviews, and establishes clarity on data ownership for intellectual property
Establish accountability with the federally financed Canadian Agency for Drugs and Technologies and Health (CADTH) and its Common Drug Review process (Health Canada)
FOOD LABELLING in respect of mitigating the unnecessary introduction of new labelling requirements for products already approved under current regulated process and in respect of maintaining harmonization of requirements with trading nations
IMPROVED TAXATION & INVESTMENT FRAMEWORK in respect of extending Canada's flow-through shares program to biotechnology companies for increased domestic investments.
IMPROVEMENTS TO THE Scientifc Research & Experimental Development TAX CREDITS in respect of updating the 20 yr old system by removing the punitive Canadian Controlled Private Companies restriction and increasing the expenditure limit for refundable credits
NOVEL FOODS in respect of maintaining a science-based regulatory system for novel foods derived from plant and animal biotechnology
PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW to ensure new guidelines and directives do not create disincentives for the introduction of new treatments in Canada
RESEARCH & DEVELOPMENT (R&D) in respect on providing input to the government's expert panel on business R&D to improve incentives for research in Canada
SCIENCE & TECHNOLOGY STRATEGY in respect of encouraging a strong government focus to stimulate the development, use and retention of biotechnology products, processes and companies
SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW to ensure Canada remains competitive overall and any new costs do not put bioloigics are a comparative disadvantage
Vaccine Funding - National Immunization Strategy - to re-establish federal leadership in providing provinces with funding for new vaccines under a renewed national immunization strategy framework
Vaccine contracting and supply
WORLD TRADE ORGANIZATION (WTO) in respect of Canada's contribution and participation to encourage a sound business climate and to faciliate Canada's access to European markets for genetically engineered agricultural and animal products

Policies or Program, Regulation

INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS in respect of creating Canada as one of the world's most competitive jurisdictions in protecting IP (e.g., match level of European Union via CETA negotiations)
ORPHAN PRODUCTS to establish formal regulations, policies or programs to encourage the research, development and introduction of new technologies to treat "orphan" or neglected diseases
REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS as NOVEL FOODS or INDUSTRIAL BIO_PRODUCTS in respect of an efficient science-based approach and allows for greater cooperation among and between government departments
Regulatory framework for subsequent entry biologics to ensure an appropriate and transparent appraoch for the safe introduction of biosimilars

Regulation

SUBSEQUENT ENTRY BIOLOGICS to establish formal regulations to prescribe the requirements for introduction of biosimilars and ensure the protection of intellectual property for first entry biologics

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Atlantic Canada Opportunities Agency (ACOA)
Business Development Bank of Canada (BDC)
Canada Revenue Agency (CRA)
Canadian Food Inspection Agency (CFIA)
Canadian Institutes of Health Research (CIHR)
Employment and Social Development Canada (ESDC)
Environment and Climate Change Canada (ECCC)
Export Development Canada (EDC)
Finance Canada (FIN)
Fisheries and Oceans Canada (DFO)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Immigration, Refugees and Citizenship Canada (IRCC)
Innovation, Science and Economic Development Canada (ISED)
Members of the House of Commons
National Defence (DND)
National Research Council (NRC)
Natural Resources Canada (NRCan)
Natural Sciences and Engineering Research Council (NSERC)
Office of the Information and Privacy Commissioner (OIPC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Procurement Review Board of Canada (PRB)
Public Health Agency of Canada (PHAC)
Public Services and Procurement Canada (PSPC)
Revenue Canada (RC)
Senate of Canada
Social Sciences and Humanities Research Council (SSHRC)
Statistics Canada (StatCan)
Technology Partnerships Canada (TPC)
Treasury Board Of Canada Secretariat (TBS)

In-house Organization Details

Description of the organization's activities

BIOTECANADA IS A NOT-FOR-PROFIT ORGANIZATION THAT IS THE VOICE FOR BIOTECHNOLOGY IN CANADA. BIOTECANADA IS DEDICATED TO THE SUSTAINABLE COMMERCIAL DEVELOPMENT OF BIOTECHNOLOGY IN CANADA. IT FOCUSES ON THE ISSUES AND ACTIVITIES AFFECTING THE CANADIAN BIOTECHNOLOGY COMMUNITY, BOTH NATIONALLY AND INTERNATIONALLY. BIOTECANADA IS INVOLVED IN MANY INITIATIVES TO ADDRESS THESE ISSUES, INCLUDING REGULATORY AND POLICY ADVOCACY, FINANCE, AND THE COLLECTION AND DISSEMINATION OF MARKET INFORMATION. BIOTECANADA, IN PARTNERSHIP WITH THE REGIONAL BIOTECHNOLOGY ASSOCIATIONS, REPRESENTS 90 PERCENT OF THE CANADIAN BIOTECHNOLOGY COMMUNITY

Responsible officer name and position during the period of this registration

ANDREW CASEY, President & CEO

Organization's membership or classes of membership

BIOTECANADA CURRENTLY HAS OVER 200 MEMBERS. THE MEMBERSHIP IS COMPRISED OF COMPANIES IN THE HUMAN HEALTH CARE, AGRICULTURAL, INDUSTRIAL, ENVIRONMENTAL AND SERVICE SECTORS AS WELL AS ASSOCIATIONS AND UNIVERSITIES. THE MEMBERSHIP CATEGORIES ARE: 1. BIOTECHNOLOGY INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH COMMERCIALIZE BIOTECHNOLOGY-DERIVED PRODUCTS AND/OR ARE ACTIVE IN BIOTECHNOLOGY RELATED R&D. 2. SERVICE INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH ARE CHARTERED BANKS OR THEIR SUBSIDIARIES; PROVIDE FINANCIAL, LEGAL, INSURANCE, CONSULTING OR OTHER SERVICES; OR PROVIDE SUPPLIES OR EQUIPMENT. 3. NOT-FOR-PROFIT: REGIONAL/SECTORAL ASSOCIATIONS, ACADEMIC ORGANIZATIONS AND PROFESSIONAL ASSOCIATIONS, GOVERNMENT DEPARTMENTS AND AGENCIES WITH A SCIENCE AND TECHNOLOGY MANDATE, OR FOREIGN ORGANIZATIONS

Government funding

No government funding was received during the last completed financial year.

In-house Organization Contact Information

Address:
600 - 1 NICHOLAS STREET
OTTAWA, ON K1N 7B7
Canada

Telephone number: 613-230-5585 Ext. 229
Fax number: 613-563-8850

Lobbyists Details

Employees who lobby for the organization

Ron Boch, VP, Biotechnology & Industry Affairs | No public offices held
ANDREW CASEY, President & CEO | Public offices held
Nadine Lunt, Sr Mgr, Communications | No public offices held
CATE MCCREADY, VP, EXTERNAL AFFAIRS | Public offices held
Iman Mohamed, Manager Health Policy | No public offices held

BIOTECANADA

The following names have been used on or after July 2, 2008

Name	From	To
BIOTECANADA	2008-07-17	current

The following names have been used before July 2, 2008

BIOTECANADA

BIOTECANADA

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Wendy Zatylny	2025-01-10	Current
ANDREW CASEY	2012-07-30	2025-01-10
Cate McCready	2012-06-01	2012-07-30
Lynn Buchanan	2012-05-07	2012-06-01
PETER BRENDERS	2005-04-05	2012-05-07

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legislative Assistant and Press Secretary Minister of State (Finance), Department of Finance	1991 to June 1993	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Legislative Assistant and Press Secretary Minister of State (Finance), Department of Finance	1991 to June 1993	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Special Assistant (Ontario) PMO, PMO	November 1997 to August 2000	Not a designated office
Director of Communications Canadian Heritage, Minister's Office	July 1997 to November 1997	Not a designated office
Communications and Legislative Assistant Indian Affairs and Northern Development, Ministers Office	January 1994 to June 1997	Not a designated office

Date Modified:: 2025-06-03

Search and menus

Language selection

Registration - In-house Organization

BIOTECANADA / Wendy Zatylny, President & CEO

Registration Information

Associated Communications

Version 30 of 36 (2015-11-11 to 2016-05-13)

Version 30 of 36 (2015-11-11 to 2016-05-13)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Description of the organization's activities

Responsible officer name and position during the period of this registration

Organization's membership or classes of membership

Government funding

In-house Organization Contact Information

Employees who lobby for the organization